New Study Shows that Progesterone May Help Spur Growth of OC in BRCA-1 Women

A new study suggests that blocking progesterone may prevent ovarian cancer. The study, "Targeting Progesterone Signaling Prevents Metastatic Ovarian Cancer" was released in the journal PNAS.

This study is important to women who have the BRCA-1 mutation. Women with this mutation generally produce high levels of progesterone during their menstrual cycles. Targeting these women with an anti-progesterone medication may provide these high risk women with an alternative to prophylactic breast or ovarian surgery.

To find out more about this study, follow this link.